Sector Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186.14 CHF | +0.96% |
|
+2.54% | - |
| Jul. 20 | Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix… |  |
| Jul. 13 | BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.07% | -3.49% | +3.71% | +14.21% | +1.90% | -3.25% | +12.87% | -22.34% | +201.60% | 46.86B | |
| +0.25% | +1.65% | +11.46% | +39.86% | +137.58% | +408.41% | +629.49% | +553.87% | - | 40.23B | |
| -0.27% | +4.45% | +17.60% | +8.34% | +7.27% | +9.93% | +66.92% | +2.83% | +1,093.77% | 36.23B | |
| +0.35% | +0.87% | +12.08% | +28.20% | -7.70% | +3.60% | -8.81% | -16.47% | +181.03% | 34.72B | |
| +3.14% | +1.02% | +2.84% | -10.78% | +3.03% | +3.37% | +38.15% | -19.55% | +142.32% | 27.89B | |
| -0.73% | +11.84% | +17.28% | +46.49% | +7.07% | +31.97% | +143.53% | +230.21% | - | 16.79B | |
| +0.47% | -2.74% | +6.66% | +10.73% | - | - | - | - | - | 16.74B | |
| +0.42% | -5.52% | -0.93% | +7.44% | +6.41% | +0.76% | +8.50% | -35.47% | +95.27% | 13.12B | |
| -2.68% | -2.49% | +4.80% | +62.24% | -9.03% | -15.00% | -31.68% | -23.96% | +129.78% | 12.7B | |
| -0.24% | -0.72% | +21.61% | +32.14% | +21.75% | +22.46% | -18.55% | -39.63% | +158.60% | 11.16B | |
| -1.48% | -5.37% | +39.78% | +17.50% | -6.31% | +93.48% | +542.37% | +259.81% | +2,678.33% | 11.07B | |
| +0.01% | +0.21% | +1.20% | +56.85% | +77.90% | +222.48% | +560.83% | - | - | 10.08B | |
| -1.21% | +8.60% | +55.30% | +31.86% | +35.53% | +37.85% | +52.61% | -55.50% | - | 9.49B | |
| +1.22% | +3.97% | -26.10% | -22.82% | -28.52% | +34.16% | +44.11% | +48.70% | +103.12% | 9.35B | |
| +0.17% | -4.49% | +10.71% | +30.22% | +42.10% | +141.16% | +404.89% | +90.15% | - | 9.1B | |
| +0.90% | +3.46% | +5.30% | -5.66% | +10.37% | +460.81% | +1,985.26% | +32.32% | - | 9.07B | |
| -0.15% | +0.32% | +4.84% | +58.78% | +89.03% | +99.36% | +66.37% | +116.05% | +6.20% | 8.82B | |
| +0.50% | -3.41% | +11.43% | +36.11% | +55.84% | +153.28% | +595.15% | +189.47% | - | 8.75B | |
| -0.19% | +0.53% | +6.82% | +7.71% | -12.60% | -23.28% | -20.79% | -28.71% | +54.71% | 8.56B | |
| Average | +0.08% | +0.28% | +10.86% | +23.65% | +23.98% | +93.42% | +281.73% | +75.40% | +440.43% | 17.93B | |
| Weighted average by Cap. | +0.32% | +0.57% | +10.40% | +21.83% | +26.12% | +89.21% | +218.83% | +93.11% | +431.52% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
